COVID-19 registry for atopic dermatitis patients (SECURE-AD) Have any of your patients with atopic dermatitis developed COVID-19? Please report your cases to SECURE-AD via a simple anonymised case report form. SECURE-AD is a global registry for healthcare professionals to report outcomes of COVID-19 in individuals with atopic dermatitis. Entering your cases is quick and can […]
Read MoreStatement from the European Task Force on Atopic Dermatitis (ETFAD) on Corona virus (Covid-19) and Atopic Dermatitis On March 11th the Director-General of the World Health Organization declared the Covid-19 to be a pandemic with wide implications for the population around the world. The total number of cases around the world is increasing exponentially and […]
Read MoreDear Colleagues, Dear Friends, Because of the COVID-19 pandemic and its consequences for international travel, the ISAD executive committee and ISAD 2020 Local Organizing Committee (LOC) have jointly decided to postpone the ISAD meeting to April 19-21 2021 at the same venue in Seoul. Information on the pre-meetings will follow in due course. Because of […]
Read MoreThe following three candidates received the first ISAD research awards: Catherine DROITCOURT Rosie VINCENT Linde de WIJS
Read MoreThe ISAD Research Fellowships are funded by a generous grant of Pfizer with the aim of supporting research training of junior Dermatologists‐Venereologists, or residents in Dermatology‐Venereology in a high standard academic center. There are two fellowships lasting 3 months and one fellowship lasting 6 months. Purpose of the Fellowship: The purpose of the fellowship is […]
Read More